A study to evaluate the Safety and Efficacy of 1 test product in reducing dark spots on the face.
- Registration Number
- CTRI/2023/03/050575
- Lead Sponsor
- Himalaya Wellness Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 42
1) Subject has at least 2 dark spots on the face (suntan, blemishes, sunspots and age-spots). Preferably equal number of subjects will be recruited in all indications.
2) Subjects with mild to moderate dark spots as per Investigator global assessment (IGA).
3) Subjects with oily skin having Sebumeter measurement > 180 (μg/cm2).
1) Subjects having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments.
2) Subjects who are receiving topical or systemic treatments / undergoing skin lightening treatment.
3) Subjects receiving medications (e.g., steroids or antihistamines) which would compromise the study.
4) Subjects with chronic illness which may influence the cutaneous state.
5) Subjects having history of diabetes, acute cardiac and circulatory diseases, HIV, hepatitis.
6) Subjects using other marketed anti-acne/anti-aging/skin lightening products during the study period or in the past 6 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Assessment of dark spots using Investigator global assessment (IGA). <br/ ><br>2) Assessment of skin pigment using 9-point scale. <br/ ><br>3) Assessment of dark spots using Mexameter. <br/ ><br>4) Assessment of skin sebum level using SebumeterTimepoint: Day 01 (before application & after application), Day 07, Day 14, Day 21 and Day 282) Assessment of skin pigment using 9-point scale. <br/ ><br>3) Assessment of dark spots using Mexameter. <br/ ><br>4) Assessment of skin sebum level using Sebumeter
- Secondary Outcome Measures
Name Time Method